Search
for
Sort by
Research 30 of 288
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- The Mask Mutation Identifies TMPRSS6 as an Essential Suppressor of Hepcidin Gene Expression, Required for Normal Uptake of Dietary Iron.
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Cutaneous signs in COVID ‐19 patients: A review
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Alopecia androgênica como agravo da infecção por SARS-CoV-2
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Matriptase-2, A Novel Suppressor of Hepcidin.
- Androgen sensitivity gateway to COVID‐19 disease severity
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- The Transmembrane Serine Protease HAT-like 4 Is Important for Epidermal Barrier Function to Prevent Body Fluid Loss
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Is COVID-19 Gender-sensitive?
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes